FDA Inspection 1216491 — KLEB Inc

KLEB Inc — FEI 3013157033

The FDA completed an inspection of KLEB Inc on August 24, 2023 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Louisville, KY (United States)